Biopharma Pipeline

To help our patients, GB Sciences is creating a pipeline for the development of novel medicines based on our own patent-pending formulations of chemicals extracted from the Cannabis plant.

Through its wholly-owned subsidiary, Growblox Life Sciences, LLC, GB Sciences has now filed five patent applications and two licenced patents.